Page 22 - Science at the nanoscale
P. 22

15:10
                                                     RPS: PSP0007 - Science-at-Nanoscale
                   June 9, 2009
                              Introduction and Historical Perspective
                          12
                                     A more promising application of bionanotechnology that has
                                   attracted much interest from researchers and industries is the
                                                                               In our modern
                                   development of nano-drug delivery systems.
                                   busy lifestyle, administration of drugs has progressed from the
                                                                                 Nanotechno-
                                   teaspoon to time-release capsules or implants.
                                   logy promises delivery mechanisms that can administer drugs at
                                   desired rates and at the exact location in the body. This requires
                                   the fabrication of precise nanostructures for drug-eluting coatings,
                                   membranes, or even implants, For example, researchers at the
                                   University of California, San Francisco have demonstrated how
                                   they can use nanotubes made from biocompatible metal oxides
                                   to hold therapeutic drugs and deliver these agents in a highly-
                                                    7
                                                      On the other hand the dendrimer, a highly
                                   controlled manner.
                                   branched polymer, has also been investigated by many as a nat-
                                   ural form of nanoparticle carrying myriad sites for drug loading.
                                   All these developments not only translate to time-saving and bet-
                                   ter treatments, they also help avoid side effects caused by large
                                   doses taken orally or by injection. There are also the potential
                                   benefits of extension of the bioavailability and economic life-
                                   span of proprietary drugs. According to the industry consulting
                                   firm NanoMarkets, nanotechnology-enabled drug delivery sys-
                                   tems are expected to generate over US$1.7 billion in 2009 and over
                                                    8
                                   $4.8 billion in 2012.
                                     Another development in nanoscience that has excited many
                                   biomedical researchers is the use of quantum dots (abbreviated
                                   QDs, see Section 6.1) in bio-imaging. These are tiny crystals that
                                   give strong fluorescence signals and, when injected into cells,
                                   allow unprecedented details inside the cells to be imaged. A nice
                                   3D imaging example was demonstrated by Cornell researchers
                                   (Fig. 1.6) whereby tiny blood vessels beneath a mouse’s skin were  ch01
                                   viewed with CdSe/ZnS QDs circulating through the bloodstream.
                                   The images appear so bright and vivid in high-resolution that
                                   researchers can see the vessel walls ripple at 640 times per minute.
                                   (b) Spintronics For many years, scientists and engineers have
                                   created a host of electrical devices that rely on electrons in the
                                   materials. Such devices include the ubiquitous transistor and the
                                   7  C. C. Lee, E. R. Gillies, M. E. Fox, S. J. Guillaudeu, J. M. Fr´echet, E. E. Dy and
                                    F. C. Szoka, Proc. Natl. Acad. Sci., USA, 103, 16649–54 (2006).
                                   8  The NanoMarkets report 2005/03 on Nano Drug Delivery: http://www.the-
                                    infoshop.com/study/nan24488 nano drug delivery.html
   17   18   19   20   21   22   23   24   25   26   27